Correction: Towards elimination: Challenges in community participation to a gHAT ‘screen and treat’ strategy using the new oral drug acoziborole in the Democratic Republic of the Congo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical studies and practices · Pharmacogenetics and Drug Metabolism · Pharmaceutical Economics and Policy
The initials of the first author are indexed incorrectly in PubMed. The correct initials are, respectively: Vander Kelen C.
The correct citation is: Vander Kelen C, Mpanya A, Nzuzi R, Watakembi G, Mbuyi C, Nicco E, et al. (2025) Towards elimination: Challenges in community participation to a gHAT ‘screen and treat’ strategy using the new oral drug acoziborole in the Democratic Republic of the Congo. PLoS Negl Trop Dis 19(6): e0013197. https://doi.org/10.1371/journal.pntd.0013197.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Kelen CV, Mpanya A, Nzuzi R, Watakembi G, Mbuyi C, Nicco E, et al. Towards elimination: Challenges in community participation to a g HAT “screen and treat” strategy using the new oral drug acoziborole in the Democratic Republic of the Congo. P Lo S Negl Trop Dis. 2025;19(6):e 0013197. doi: 10.1371/journal.pntd.0013197 40540511 PMC 12221165 · doi ↗ · pubmed ↗